Vice President, Technical Operations, Cell Therapy
Mr. Jerrod Denham brings over two decades of experience developing cell and gene therapy products. He has provided strategic and technical CMC consultation for over 70 US and international cell and gene therapy clients, ranging from small private biotech companies to large public biotech companies and pharmaceutical organizations. Jerrod is a technical expert in both autologous and allogeneic cell therapy manufacturing processes, including for genetically modified cell therapy products. He has authored CMC sections and several CMC amendments in support of 20 different corporate sponsored FDA approved INDs for cell and gene therapy drug products.
Prior to joining Athenex, Mr. Dunham served as VP of Manufacturing and Site Lead at Resilience, a manufacturing and technology company dedicated to building a network of high-tech manufacturing solutions to make medicines quickly, safely, and at scale.